Genetic and pharmacogenetic aspects of alcohol-dependence

Current Pharmacogenomics

Volumn 4, Issue 1, 2006, Pages 19-32

  Ramoz, Nicolas ^a   Schumann, Gunter ^b,c   Gorwood, Philip ^a,d  

^a INSERM   (France)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HÔPITAL LOUIS MOURIER   (France)

Author keywords

CB1 gene; DRD2 receptors; Flushing Syndrome; MAP kinase; Neurotransmitter; Opioids

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ACAMPROSATE; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BROMOCRIPTINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CITALOPRAM; CYTOCHROME P450 2E1; DISULFIRAM; DOPAMINE; ENKEPHALIN DERIVATIVE; FLUOXETINE; GLUTAMIC ACID; MOOD STABILIZER; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALTREXONE; NICOTINE; NORADRENALIN; ONDANSETRON; OPIATE RECEPTOR; RECEPTOR SUBUNIT; RIMONABANT; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; UNINDEXED DRUG; VIQUALINE;

ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALLELE; ANXIETY DISORDER; BIPOLAR DISORDER; CLINICAL TRIAL; DRUG EFFICACY; DRUG RECEPTOR BINDING; ENVIRONMENTAL FACTOR; FLUSHING; GENE EXPRESSION PROFILING; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; INHERITANCE; MENTAL DISEASE; NONHUMAN; PERSONALITY DISORDER; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; PROTEIN EXPRESSION; PROTEOMICS; PSYCHOPATHY; REVIEW; RODENT; TRANSCRIPTOMICS;

RODENTIA;

EID: 33646123563     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016006776055383     Document Type: Review

References (134)

1. Arlinde, C.; Sommer, W.; Bjork, K.; Reimers, M.; Hyytia, P.; Kiianmaa, K. and Heilig, M. (2004) A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism. Pharmacogenomics J. 4, 208-218.
2. Bergen, A.; Kokoszka, J.; Peterson, R.; Long, J.; Virkkunen, M.; Linnoila, M. and Goldman, D. (1997) Mu-opioid receptor gene variants: lack of association with alcohol dependence. Mol. Psychiatry 2, 490-494.
3. Berglund, M.; Thelander, S.; Salaspuro, M.; Franck, J.; Andreasson, S. and Ojehagen, A. (2003) Treatment of alcohol abuse: an evidence-based review. Alcohol. Clin. Exp. Res. 27, 1645-1656.
4. Bond, C.; LaForge, K.; Tian, M.; Melia, D.; Zhang, S.; Borg, L.; Gong, J.; Schluger, J.; Strong, J. A.; Leal, S. M.; Tischfield, J. A.; Kreek, M. J. and Yu, L. (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl. Acad. Sci. USA 95, 9608-9613.
5. Bönsch, D.; Lederer, T.; Reulbach, U.; Hothorn, T.; Kornhuber, J. and Bleich, S. (2005) Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence. Hum. Mol. Genet. 14, 967-971.
6. Bowers, B. J.; McClure-Begley, T. D.; Keller, J. J.; Paylor, R.; Collins, A. C. and Wehner, J. M. (2005) Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol. Alcohol Clin. Exp. Res. 29, 295-302.
7. Buck, K. J.; Metten, P.; Belknap, J. K. and Crabbe, J. C. (1997) Quantitative trait loci involved in genetic predisposition to acute alcohol withdrawal in mice. J. Neurosci. 17, 3946-3955.
8. Chen, S. Y.; Liu, T. Y.; Shun, C. T.; Wu, M. S.; Lu, T. H.; Lin, J. T.; Sheu, J. C.; Santella, R. M. and Chen, C. J. (2004) Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. Int. J. Cancer. 108, 606-612.
9. Choi, J. Y.; Abel, J.; Neuhaus, T.; Ko, Y.; Harth, V.; Hamajima, N.; Tajima, K.; Yoo, K. Y.; Park, S. K.; Noh, D. Y.; Han, W.; Choe, K. J.; Ahn, S. H.; Kim, S. U.; Hirvonen, A. and Kang, D. (2003) Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development. Pharmacogenetics 13, 67-72.
10. COMBINE Study Research Group. (2003) Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. Alcohol. Clin. Exp. Res. 27(7), 1107-22.
11. Comings, D. E. and Blum, K. (2000) Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog. Brain Res. 126, 325-341.
12. Crowley, J. J.; Oslin, D. W.; Patkar, A. A.; Gottheil, E.; DeMaria, P. A. Jr.; O'Brien, C. P.; Berrettini, W. H. and Grice, D. E. (2003) A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr. Genet. 13, 169-173.
13. Davis, K. M. and Wu, J. Y. (2001) Role of glutamatergic and GABAergic systems in alcoholism. J. Biomed. Sci. 8, 7-19.
14. Depaz, I. M.; de Las Heras, R.; Kroon, P. A. and Wilce, P. A. (2005) Changes in neuronal protein 22 expression and cytoskeletal association in the alcohol-dependent and withdrawn rat brain. J. Neurosci. Res. 81, 253-260.
15. Edenberg, H. J.; Dick, D. M.; Xuei, X.; Tian, H.; Almasy, L.; Bauer, L. O.; Crowe, R. R.; Goate, A.; Hesselbrock, V.; Jones, K.; Kwon, J.; Li, T. K.; Nurnberger, J. I. Jr.; O'Connor, S. J.; Reich, T.; Rice, J.; Schuckit, M. A.; Porjesz, B.; Foroud, T. and Begleiter, H. (2004) Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am. J. Hum. Genet. 74, 705-714.
16. Ehlers, C. L.; Gilder, D. A.; Wall, T. L.; Phillips, E.; Feiler, H. and Wilhelmsen, K. C. (2004) Genomic screen for loci associated with alcohol dependence in Mission Indians. Am. J. Med. Genet. 129, 110-115.
17. Ehlers, C. L. and Wilhelmsen, K. C. (2005) Genomic scan for alcohol craving in Mission Indians. Psychiatr. Genet. 15, 71-75.
18. Engel, S. R. and Allan, A. M. (1999) 5-HT3 receptor over-expression enhances ethanol sensitivity in mice. Psychopharmacology 144, 411-415.
19. Engel, S. R.; Lyons, C. R. and Allan, A. M. (1998) 5-HT3 receptor over-expression decreases ethanol self administration in transgenic mice. Psychopharmacology 140, 243-248.
20. Enoch, M A (2003) Pharmacogenomics of alcohol response and addiction. Am. J. Pharmacogenomics 3, 217-232.
21. Fan, L; Jaquet, V.; Dodd, P. R.; Chen, W. and Wilce, P. A. (2001) Molecular cloning and characterization of hNP22: a gene upregulated in human alcoholic brain. J. Neurochem. 76, 1275-1281.
22. Fehr, C.; Rademacher, B. L. and Buck, K. J. (2003) Evaluation of the glutamate decarboxylase genes Gad1 and Gad2 as candidate genes for acute ethanol withdrawal severity in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 467-472.
23. Feinn, R.; Nellissery, M. and Kranzler, H. R. (2005) Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am. J. Med. Genet. 133, 79-84.
24. Foley, P. F.; Loh, E. W.; Innes, D. J.; Williams, S. M.; Tannenberg, A. E.; Harper, C. G. and Dodd, P. R. (2004) Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians. Ann. N. Y. Acad. Sci. USA 1025, 39-46.
25. Foroud, T.; Edenberg, H. J.; Goate, A.; Rice, J.; Flury, L.; Koller, D. L.; Bierut, L. J.; Conneally, P. M.; Nurnberger, J. I.; Bucholz, K. K.; Li, T. K.; Hesselbrock, V.; Crowe, R.; Schuckit, M.; Porjesz, B.; Begleiter, H. and Reich, T. (2000) Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. Alcohol Clin. Exp. Res. 24, 933-945.
26. Franke, P.; Schwab, S. G.; Knapp, M.; Gansicke, M.; Delmo, C.; Zill, P.; Trixler, M.; Lichtermann, D.; Hallmayer, J.; Wildenauer, D. B. and Maier, W. (1999) DAT1 gene polymorphism in alcoholism: a family-based association study. Biol. Psychiatry 45, 652-654.
27. Franke, P.; Wang, T.; Nöthen, M.; Knapp, M.; Neidt, H.; Albrecht, S.; Jahnes, E.; Propping, P. and Maier, W. (2001) Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am. J. Med Genet. 105, 114-119.
28. Froehlich, J. C. (1997) Opioid Peptides. Alcohol Health Res. 21, 132-136.
29. Fu, Q.; Heath, A. C.; Bucholz, K. K.; Nelson, E.; Goldberg, J.; Lyons, M. J.; True, W. R.; Jacob, T.; Tsuang, M. T. and Eisen, S. A. (2002) Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. Arch. Gen. Psychiatry 59, 1125-1132.
30. Garbutt, J. C.; Kranzler, H. R.; O'Malley, S. S.; Gastfriend, D. R.; Pettinati, H. M.; Silverman, B. L.; Loewy, J. W. and Ehrich, E. W. (2005) Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 293, 1617-1625.
31. Gelernter, J.; Kranzler, H. and Cubells, J. (1999) Genetics of two mu opioid receptor gene (OPRM1) exon 1 polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol. Psychiatry 4, 476-483.
32. Gianoulakis, C. (2001) Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J. Psychiatry Neurosci. 26, 304-318.
33. Goedde, H. and Agarwal, D. (1987) Polymorphism of aldehyde dehydrogenase and alcohol sensitivity. Enzyme 37, 29-44.
34. Gorwood, P.; Batel, P.; Gouya, L.; Courtois, F.; Feingold, J. and Ades, J. (2000) Reappraisal of the association between the DRD2 gene, alcoholism and addiction. Eur. Psychiatry 15, 90-96.
35. Gorwood, P.; Limosin, F.; Batel, P.; Hamon, M.; Ades, J. and Boni, C. (2003) The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol. Psychiatry 53, 85-92.
36. Gorwood, P.; Batel, P.; Ades, J.; Hamon, M. and Boni, C. (2000) Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol. Psychiatry 48, 259-264.
37. Grant, B. F.; Stinson, F. S.; Dawson, D. A.; Chou, S. P.; Dufour, M. C.; Compton, W.; Pickering, R.P. and Kaplan, K. (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 61, 807-816.
38. Gscheidel, N.; Sander, T.; Wendel, B.; Heere, P.; Schmidt, L. G.; Rommelspacher, H.; Hoehe, M. R. and Samochowiec, J. (2000) Five exon 1 variants of mu opioid receptor and vulnerability to alcohol dependence. Pol. J. Pharmacol. 52, 27-31.
39. Hasin, D. S. and Grant, B. F. (2004) The co-occurrence of DSM-IV alcohol abuse in DSM-IV alcohol dependence: results of the National Epidemiologic Survey on alcohol and Related Condition on heterogeneity that differ by population subgroup. Arch. Gen. Psychiatry 61, 891-896.
40. Hassan, S.; Duong, B.; Kim, K. S. and Miles, M. F. (2003) Pharmacogenomic analysis of mechanisms mediating ethanol regulation of dopamine beta-hydroxylase. J. Biol. Chem. 278, 38860-38869.
41. Hayashi, S.; Watanabe, J. and Kawajiri, K. (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1. J. Biochem. 110, 559-565.
42. Heinz, A.; Goldman, D.; Jones, D. W.; Palmour, R.; Hummer, D.; Gorey, J. G.; Lee, K. S.; Linnoila, M. and Weinberger, D. R. (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22, 133-139.
43. Herman, A. I.; Kaiss, K. M.; Ma, R.; Philbeck, J. W.; Hasan, A.; Dasti, H. and DePetrillo, P. B. (2005) Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women. Am. J. Med. Genet. 133, 74-78.
44. Herz, A. (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology 129, 99-111.
45. Hicks, B. M.; Krueger, R. F.; Iacono, W. G.; McGue, M. and Patrick, C. J. (2004) Family transmission and heritability of externalizing disorders: a twin-family study. Arch. Gen. Psychiatry 61, 922-928.
46. Hietala, J. (1999) Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol. Psychiatry 4, 286-289.
47. Hill, S. Y.; Shen, S.; Zezza, N.; Hoffman, E. K.; Perlin, M. and Allan, W. (2004) A genome wide search for alcoholism susceptibility genes. Am. J. Med. Genet. 128, 102-113.
48. Hoehe, M. R.; Kopke, K.; Wendel, B.; Rohde, K.; Flachmeier, C.; Kidd, K. K; Berrettini, W. H. and Church, G. M. (2000) Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum. Mol. Genet. 9, 2895-2908.
49. Hopfer, C. J.; Timberlake, D.; Haberstick, B.; Lessem, J. M.; Ehringer, M. A.; Smolen, A. and Hewitt, J. K. (2005) Genetic influences on quantity of alcohol consumed by adolescents and young adults. Drug Alcohol Depend. 78, 187-193.
50. Hsu, L. C.; Tani, K.; Fujiyoshi, T.; Kurachi, K. and Yoshida, A. (1985) Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proc. Natl. Acad. Sci. 82, 3771-3775.
51. Hu, X.; Oroszi, G.; Chun, J.; Smith, T. L.; Goldman, D. and Schuckit, M. A. (2005) An expanded evaluation of the relationship of four alleles to level of response to alcohol and the alcoholism risk. Alcohol Clin. Exp. Res. 29, 8-16.
52. Hu, Y.; Oscarson, M.; Johansson, L; Yue, Q. Y.; Dahl, M. L.; Tabone, M.; Arinco, S.; Albano, E. and Ingelman-Sundberg, M. (1997) Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol. Pharmacol. 51, 370-376.
53. Hungund, B. L. and Basavarajappa, B. S. (2004) Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors. Ann. N. Y. Acad. Sci. 1025, 515-527.
54. Johnson, B. A.; Ait-Daoud, N. and Prihoda, T. J. (2000) Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence. Alcohol Clin. Exp. Res. 24, 737-742.
55. Johnson, B. A. (2004) Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment. CNS Drugs 18, 1105-1118.
56. Kessler, R. C.; Crum, R. M.; Warner, L. A.; Nelson, C. B.; Schulenberg, J. and Anthony, J. C. (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch. Gen. Psychiatry 54, 313-321.
57. Kim, S. A.; Kim, J. W.; Song, J. Y.; Park, S.; Lee, H. J. and Chung, J. H. (2004) Association of polymorphisms in nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4), μ-opioid receptor gene (OPRM1), and ethanol-metabolizing enzyme genes with alcoholism in Korean patients. Alcohol 34, 115-120.
58. Kranzler, H. R.; Gelernter, J.; O'Malley, S.; Hernandez-Avila, C. A. and Kaufman, D. (1998) Association of alcohol or other drug dependence with alleles of the μ-Opioid Receptor Gene (OPRMI). Alcoholism: Clin. Exp. Res. 22, 1359-1362.
59. Kranzler, H. R.; Pierucci-Lagha, A.; Feinn, R. and Hernandez-Avila, C. (2003) Effects of ondansetron in early - versus late-onset alcoholics' a prospective, open-label study. Alcohol Clin. Exp. Res. 27, 1150-1155.
60. Kranzler, H. R.; Wesson, D. R. and Billot, L. (2004) DrugAbuse Sciences Naltrexone Depot Study Group. Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcohol Clin. Exp. Res. 28, 1051-1059.
61. Kreek, M. J.; Bart, G.; Lilly, C.; LaForge, K. S. and Nielsen, D. A. (2005) Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol. Rev. 57, 1-26.
62. Krystal, J. H.; Cramer, J. A.; Krol, W. F.; Kirk, G. F. and Rosenheck, R. A. (2001) Veterans Affairs Naltrexone Cooperative Study. Naltrexone in the treatment of alcohol dependence, New Engl. J. Med. 345, 1734-1739.
63. Kumari, M. and Ticku, M. K. (2000) Regulation of NMDA receptors by ethanol. Prog Drug Res. 54, 152-189.
64. Kweon, Y. S.; Lee, H. K.; Lee, C. T. and Pae, C. U. (2005) Association study of catechol-O-methyltransferase gene polymorphism in Korean male alcoholics. Psychiatr. Genet. 15, 151-154.
65. Lappalainen, J.; Long, J. C.; Eggert, M.; Ozaki, N.; Robin, R. W.; Brown, G. L.; Naukkarinen, H.; Virkkunen, M.; Linnoila, M. and Goldman, D. (1998) Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch. Gen. Psychiatry 55, 989-994.
66. Lappalainen, J.; Kranzler, H. R.; Petrakis, L; Somberg, L. K.; Page, G.; Krystal, J. H. and Gelernter, J. (2004) Confirmation and fine mapping of the chromosome 1 alcohol dependence risk locus. Mol. Psychiatry 9, 312-319.
67. Lawford, B. R.; Young, R. M.; Rowell, J. A.; Qualichefski, J.; Fletcher, B. H.; Syndulko, K.; Ritchie, T. and Noble, E. P. (1995) Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nat. Med 1, 337-341.
68. Le Foll, B. and Goldberg, S. R. (2005) Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J. Pharmacol. Exp. Ther. 312, 875-883.
69. Schmidt, L. G.; Samochowiec, J.; Finckh, U.; Fiszer-Piosik, E.; Horodnicki, J.; Wendel, B.; Rommelspacher, H. and Hoehe, M. R. (2002) Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend. 65, 221-224.
70. Lesch, K. P.; Bengel, D.; Heils, A.; Sabol, S. Z.; Greenberg, B. D.; Petri, S.; Benjamin, J.; Muller, C. R.; Hamer, D. H. and Murphy, D. L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
71. Lewohl, J. M.; Van Dyk, D. D.; Craft, G. E.; Innes, D. J.; Mayfield, R. D.; Cobon, G.; Harris, R. A. and Dodd, P. R. (2004) The application of proteomics to the human alcoholic brain. Ann. N. Y. Acad. Sci. USA 1025, 14-26.
72. Lin, Z.; Walther, D.; Yu, X. Y.; Li, S.; Drgon, T. and Uhl, G. R. (2005) SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism. Hum. Mol. Genet. 14, 1393-1404.
73. Loh, E. W.; Higuchi, S.; Matsushita, S.; Murray, R.; Chen, C. K. and Ball, D. (2000) Association analysis of the GABA(A) receptor subunit genes cluster on 5q33-34 and alcohol dependence in a Japanese population. Mol. Psychiatry 5, 301-307.
74. Lötsch, J. and Geisslinger, G. (2005) Are mu-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol. Med. 11, 82-89.
75. Lovinger, D. M.; White, G. and Weight, F. F. (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243, 1721-1724.
76. Lovinger, D. M. (1997) Serotonin's role in alcohol's effects on the brain. Alcohol Health & Research World 21, 114-120.
77. Maiya, R. and Mayfield, R. D. (2004) Dopamine transporter network and pathways. Int. Rev. Neurobiol. 61, 79-96.
78. Mann, K. (2004) Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 18, 485-504.
79. Mann, K.; Lehert, P. and Morgan, M. Y. (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin. Exp. Res. 28, 51-63.
80. Matsuda, L. A.; Lolait, S. J.; Brownstein, M. J.; Young, A. C. and Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
81. Michaelis, E. K. (1998) Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54, 369-415.
82. Naranjo, C. A. and Knoke, D. M. (2001) The role of selective serotonin reuptake inhibitors in reducing alcohol consumption. J Clin. Psychiatry 62, 18-25.
83. Nelson, E. C.; Grant, J. D.; Bucholz, K. K.; Glowinski, A.; Madden, P. A. F.; Reich, W. and Heath, A. C. (2000) Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms. Psychol. Med. 30, 797-804.
84. Neuhold, L. A.; Guo, Q. M.; Alper, J. and Velazquez, J. M. (2004) High-throughput proteomics for alcohol research. Alcohol Clin. Exp. Res. 28, 203-210.
85. Nevo, I. and Hamon, M. (1995) Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem. Int. 26, 305-336.
86. Nomura, F.; Itoga, S.; Uchimoto, T.; Tomonaga, T.; Nezu, M.; Shimada, H. and Ochiai, T. (2003) Transcriptional activity of the tandem repeat polymorphism in the 5′-flanking region of the human CYP2E1 gene. Alcohol Clin. Exp. Res. 27, 42S-46S.
87. Oroszi, G. and Goldman, D. (2004) Alcoholism. genes and mechanisms. Pharmacogenomics 5, 1037-1048.
88. Oslin, D. W.; Berrettini, W.; Kranzler, H. R.; Pettinati, H.; Gelernter, J.; Volpicelli, J. R. and O'Brien, C. P. (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28, 1546-1552.
89. Parsian, A. and Zhang, Z. H. (1999) Human chromosomes 11p15 and 4p12 and alcohol dependence: possible association with the GABRB1 gene. Am. J. Med. Genet. 98, 533-538.
90. Pastino, G. M.; Flynn, E. J. and Sultatos, L. G. (2000) Genetic polymorphisms in ethanol metabolism: issues and goals for physiologically based pharmacokinetic modelling. Drug Chem. Toxicol. 23, 179-201.
91. Pandey, S. C. (1998) Neuronal signaling systems and ethanol dependence. Mol. Neurobiol. 17, 1-15.
92. Preuss, U. W.; Koller, G.; Zill, P.; Bondy, B. and Soyka, M. (2003) Alcoholism-related phenotypes and genetic variants of the CB1 receptor. Eur. Arch. Psychiatry Clin. Neurosci. 253, 275-280.
93. Preuss, U. W.; Koller, G.; Soyka, M. and Bondy, B. (2001) Association between suicide attempts and 5-HTTLPR-S-allete in alcohol-dependent and control subjects: further evidence from a German alcohol-dependent inpatient sample. Biol. Psychiatry 50, 636-639.
94. Radel, M.; Vallejo, R. L.; Iwata, N.; Aragon, R.; Long, J. C.; Virkkunen, M. and Goldman, D. (2005) Haplotype-based localization of an alcohol dependence gene to the 5q34 {gamma}-aminobutyric acid type A gene cluster. Arch. Gen. Psychiatry 62, 47-55.
95. Raimondi, S.; Benhamou, S.; Coutelle, C.; Garte, S.; Hayes, R.; Kiemeney, L.; Lazarus, P.; Marchand, L. L.; Morita, S.; Povey, A.; Romkes, M.; Zijno, A. and Taioli, E. (2004) Association of metabolic gene polymorphisms with alcohol consumption in controls. Biomarkers 9, 180-189.
96. Reich, T.; Edenberg, H. J.; Goate, A.; Williams, J. T.; Rice, J. P.; Van Eerdewegh, P.; Foroud, T.; Hesselbrock, V.; Schuckit, M. A.; Bucholz, K.; Porjesz, B.; Li, T. K.; Conneally, P. M.; Nurnberger, J. I. Jr.; Tischfield, J. A.; Crowe, R. R.; Cloninger, C.R.; Wu, W.; Shears, S.; Carr, K.; Crose, C.; Willig, C. and Begleiter, H. (1998) Genome-wide search for genes affecting the risk for alcohol dependence. Am. J. Med. Genet. 81, 207-215.
97. Risch, N. J. (2000) Searching for genetic determinants in the new millennium. Nature 405, 847-856.
98. Robinson, T. E. and Berridge, K. C. (1993) The neural basis of drug craving: anincentiv-sensitization theory od addiction. Brain Res. Rev. 18, 247-291.
99. Rommelspacher, H.; Smolka, M.; Schmidt, L.; Samochowiec, J. and Hoehe, M. R. (2001) Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals. Alcohol 24, 129-135.
100. Rujescu, D.; Soyka, M.; Dahmen, N.; Preuss, U.; Hartmann, A. M.; Giegling, I.; Koller, G.; Bondy, B.; Moller, H. J. and Szegedi, A. (2005) GRIN1 locus may modify the susceptibility to seizures during alcohol withdrawal. Am. J. Med. Genet. 133, 85-87.
101. Samochowiec, J.; Kucharska-Mazur, J.; Kaminski, R.; Smolka, M.; Rommelschpacher R; Wernicke, C; Tymicz A and Schimdt, L. G. (2002) Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence. Psychiatry Res. 111, 229-233.
102. Sander, T.; Gscheidel, N.; Wendel, B.; Samochowiec, J.; Smolka, M.; Rommelspacher, H.; Schmidt, L. G. and Hoehe, M. R. (1998) Human mu-opioid receptor variation and alcohol dependence. Alcoholism: Clin. Exv. Res. 22, 2108-2110.
103. Sander, T.; Ostapowicz, A.; Samochowiec, J.; Smolka, M.; Winterer, G. and Schmidt, L. G. (2000) Genetic variation of the glutamate transporter EAAT2 gene and vulnerability to alcohol dependence. Psychiatr. Genet. 10, 103-107.
104. Sander, T.; Harms, H.; Podschus, J.; Finckh, U.; Nickel, B.; Rolfs, A.; Rommelspacher, H. and Schmidt, L. G. (1997) Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol. Psychiatry 41, 299-304.
105. Schinka, J.; Town, T.; Abdullah, L.; Crawford, F.; Ordorica, P.; Francis, E.; Hughes, P.; Graves, A. B.; Mortimer, J. A. and Mullan, M. (2002) A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol. Psychiatry 7, 224-228.
106. Schmidt, L. G.; Harms, H.; Kuhn, S.; Rommelspacher, H. and Sander, T. (1998) Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am. J. Psychiatry 155, 474-478.
107. Schuckit, M. A.; Mazzanti, C.; Smith, T. L.; Ahmed, U.; Radel, M.; Iwata, N. and Goldman, D. (1999) Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol. Psychiatry 45, 647-551.
108. Schumann, G.; Rujescu, D.; Szegedi, A.; Singer, P.; Wiemann, S.; Wellek, S.; Giegling, I.; Klawe, C.; Anghelescu, I.; Heinz, A.; Spanagel, R.; Mann, K.; Henn, F. A. and Dahmen, N. (2003a) No association of alcohol dependence with a NMDA-receptor 2B gene variant. Mol. Psychiatry 8, 11-12.
109. Schumann, G.; Rujescu, D.; Kissling, C.; Soyka, M.; Dahmen, N.; Preuss, U. W.; Wieman, S.; Depner, M.; Wellek, S.; Lascorz, J.; Bondy, B.; Giegling, I.; Anghelescu, I.; Cowen, M. S.; Poustka, A.; Spanagel, R.; Mann, K.; Henn, F. A. and Szegedi, A. (2003b) Analysis of genetic variations of protein tyrosine kinase fyn and their association with alcohol dependence in two independent cohorts. Biol. Psychiatry 54, 1422-1426.
110. Smith, A. P. and Lee, N. M. (2003) Opioid receptor interactions: Local and nonlocal, symmetric and asymmetric, physical and functional. Life Sciences 73, 1873-1893.
111. Sommer, W. H; Arlinde, C. and Heilig, M. (2005) The search for candidate genes of alcoholism: evidence from expression profiling studies. Addict. Biol. 10, 71-79.
112. Spanagel, R. and Bienkowski, P. (2002) Glutamatergic mechanisms in alcohol dependence and addiction. In Therapeutic Potential of Ionotropic Glutamate Receptor Antagonists and Modulators; Lodge, D.; Danysz, W. and Parsons, F. P.; Eds.; (Hrsg) Graham Publishing Co., pp. 375-403.
113. Spanagel, R.; Pendyala, G.; Abarca, C.; Zghoul, T.; Sanchis-Segura, C.; Magnone, M. C.; Lascorz, J.; Depner, M.; Holzberg, D.; Soyka, M.; Schreiber, S.; Matsuda, F.; Lathrop, M.; Schumann, G. and Albrecht, U. (2005) The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat. Med. 11, 35-42.
114. Stromberg, P.; Svensson, S.; Berst, K. B.; Plapp, B. V. and Hoog, J. O. (2004) Enzymatic mechanism of low-activity mouse alcohol dehydrogenase 2. Biochemistry 43, 1323-1328.
115. Tabakoff, B.; Bhave, S. V. and Hoffman, P. L. (2003) Selective breeding, quantitative trait locus analysis, and gene arrays identify candidate genes for complex drug-related behaviors. J. Neurosci. 23, 4491-4498.
116. Takeshita, T.; Morimoto, K.; Mao, X. Q.; Hashimoto, T. and Furuyama, J. (1994) Characterization of the three genotypes of low Km aldehyde dehydrogenase in a Japanese population. Hum. Genet. 94, 217-223.
117. Thibault, C.; Hassan, S. and Miles, M. (2005) Using in vitro models for expression profiling studies on ethanol and drugs of abuse. Addict. Biol. 10, 53-62.
118. Tiihonen, J.; Hallikainen, T.; Lachman, H.; Saito, T.; Volavka, J.; Kauhanen, I.; Salonen I. T.: Ryynanen, O P; Koulu, M.; Karvonen, M. K.; Pohjalainen, T.; Syvalahti, E. and Hietala, J. (1999) Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol. Psychiatry 4, 286-289.
119. Town, T.; Abdullah, L.; Crawford, F.; Schinka, J.; Ordorica, P.; Francis, E.; Hughes, P.; Duara, R. and Mullan, M. (1999) Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am. J. Med. Genet. 88, 458-461.
120. True, W. R.; Xian, H.; Scherrer, J. F.; Madden, P. A.; Bucholz, K. K.; Heath, A. C.; Eisen, S. A.; Lyons, M. J.; Goldberg, J. and Tsuang, M. (1999) Common genetic vulnerability for nicotine and alcohol dependence in men. Arch. Gen. Psychiatry 56, 655-661.
121. Tsai, G. and Coyle, J. T. (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Ann. Rev. Med. 49, 173-84.
122. Tyndale, R. F. (2003) Genetics of Alcoholism and Tobacco Use in Humans. Ann. of Medicine 35, 94-121.
123. Verheul, R.; Van Den Brink, W. and Geerlings, P. (1999) A three-pathway psychobiological model of craving for alcohol, Alcohol Alcohol 34, 197-222.
124. Verlaan, M.; Te Morsche, R. H.; Roelofs, H. M.; Laheij, R. J.; Jansen, J. B.; Peters, W. H. and Drenth, J. P. (2004) Genetic polymorphisms in alcohol-metabolizing enzymes and chronic pancreatitis. Alcohol Alcohol. 39, 20-24.
125. Wall, T. L.; Carr, L. G. and Ehlers, C. L. (2003) Protective association of genetic variation in alcohol dehydrogenase with alcohol dependence in Native American Mission Indians. Am. J. Psychiatry 160, 41-46.
126. Wand, G. S.; Mangold, D.; El Deiry, S.; McCaul, M. E. and Hoover, D. (1998) Family history of alcoholism and hypothalamic opioidergic activity. Arch. Gen. Psychiatry 55, 1114-1119.
127. Wand, G. S. McCaul, M.; Yang, X.; Reynolds, J.; Gotjen, D.; Lee, S. and Ali, A. (2002) The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26, 106-114.
128. Wang, J. C.; Hinrichs, A. L.; Stock, H.; Budde, J.; Allen, R.; Bertelsen, S.; Kwon, J. M.; Wu, W.; Dick, D. M.; Rice, J.; Jones, K.; Nurnberger, J. I. Jr.; Tischfield, J.; Porjesz, B.; Edenberg, H. J.; Hesselbrock, V.; Crowe, R.; Schuckit, M.; Begleiter, H.; Reich, T.; Goate, A. M. and Bierut, L. J. (2004) Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum. Mol. Genet. 13, 1903-1911.
129. Wernicke, C.; Smolka, M.; Gallinat, J.; Winterer, G.; Schmidt, L. G. and Rommelspacher, H. (2002) Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population. Neurosci. Lett. 15, 45-48.
130. Wernicke, C.; Samochowiec, J.; Schmidt, L. G.; Winterer, G.; Smolka, M.; Kucharska-Mazur, J.; Horodnicki, J.; Gallinat, J. and Rommelspacher, F. (2003) Polymorphisms in the N-methyl-D-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits. Biol. Psychiatry 54, 922-928.
131. Winokur, G.; Coryell, W.; Endicott, J.; Keller, M.; Akiskal, H. and Solomon, D. (1996) Familial alcoholism in manic-depressive (bipolar) disease. Am. J. Med. Genet. 67, 197-201.
132. Witzmann, F. A.; Li, J.; Strother, W. N.; McBride, W. J.; Hunter, L.; Crabb, D. W.; Lumeng, L. and Li, T. K. (2003) Innate differences in protein expression in the nucleus accumbens and hippocampus of inbred alcohol-preferring and -nonpreferring rats. Proteomics 3, 1335-1344.
133. Witzmann, F. A. and Strother, W. N. (2004) Proteomics and alcoholism. Int. Rev. Neurobiol. 61, 189-214.
134. Yao, L.; Arolfo, M. P.; Dohrman, D. P.; Jiang, Z.; Fan, P.; Fuchs, S.; Janak, P. H.; Gordon, A. S. and Diamond, I. (2002) betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell 109, 733-743.